Document Detail

The value of the insulin-like growth factor binding protein-1 in the cervical-vaginal secretion detected by immunochromatographic dipstick test in the prediction of delivery in women with clinically unconfirmed preterm premature rupture of membranes.
MedLine Citation:
PMID:  16054956     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: The aim of this study was to determine the value of detecting insulin-like growth factor binding protein-1 (IGFBP-1) in the cervical-vaginal secretion in the prediction of delivery in women with clinically uncorfirmed preterm premature rupture of membranes (PPROM). MATERIAL AND METHODS: A total of 87 women, gestational age between 20 and 36 weeks were enrolled into this prospective study. Based on the clinical diagnosis, patients were grouped as clinically evident PPROM (n = 25), clinically suspected PPROM (n = 42) and women with intact fetal membranes (n = 20). Detection of IGFBP-1 in the cervical-vaginal secretions was done using a one-step immunochromatographic dipstick test in all women. The outcome measures were gestational age at delivery, neonatal birth weight and duration of the interval between the test and delivery between women with positive and negative test results. RESULTS: The test was positive in all 25 women (100% sensitivity) with clinically evident PPROM and all delivered prematurely, and negative in 19 out of the 20 (95% specificity) women with intact fetal membranes. Among 36 women with clinically suspected PPROM, 13 (36%) tested positive and 23 (63%) tested negative for IGFBP-1. In this group, the mean gestational age and birth weight at the time of delivery were significantly lower in patients with positive test (31.38+/-2.6 weeks versus 38.61+/-0.99 weeks and 1761+/-527g versus 3500+/-355g, P < 0.05 for both). Eleven (85%) of the 13 women with positive test, delivered within 2 weeks after the performance of the test whereas all the women with negative test results delivered after 2 weeks (P = 0.001). The test had 100, 92, 84 and 100% sensitivity, specificity, positive predictive value and negative predictive value, respectively, for the outcome measure of test-delivery interval. CONCLUSION: The screening test for IGFBP-1 in the cervical-vaginal secretions is a useful adjunct in the prediction of delivery in women with clinically unconfirmed PPROM.
Fuat Akercan; Teksin Cirpan; Mert Kazandi; Mustafa Cosan Terek; Leila Mgoyi; Erdinc Ozkinay
Related Documents :
10782746 - Candida vaginitis: self-reported incidence and associated costs.
8389516 - Factors influencing vaginal cytology, ph and bacterial flora in elderly women.
369376 - Group b streptococcal colonization and antibody status in lower socioeconomic parturien...
3540896 - Role of ureaplasma urealyticum in amnionitis.
2513266 - Gender differences in caregiving: why do wives report greater burden?
15901126 - The influence of gender and age on hamstring muscle length in healthy adults.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of obstetrics, gynecology, and reproductive biology     Volume:  121     ISSN:  0301-2115     ISO Abbreviation:  Eur. J. Obstet. Gynecol. Reprod. Biol.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-01     Completed Date:  2005-12-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375672     Medline TA:  Eur J Obstet Gynecol Reprod Biol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  159-63     Citation Subset:  IM    
Department of Obstetrics and Gynecology, Ege University Faculty of Medicine, 35100 Bornova, Izmir, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bodily Secretions / chemistry*
Cervix Uteri / secretion*
Delivery, Obstetric
Fetal Membranes, Premature Rupture / diagnosis*
Insulin-Like Growth Factor Binding Protein 1
Insulin-Like Growth Factor Binding Proteins / analysis*
Predictive Value of Tests
Pregnancy Proteins / analysis*
Prospective Studies
Reagent Strips
Vagina / secretion
Reg. No./Substance:
0/IGFBP1 protein, human; 0/Insulin-Like Growth Factor Binding Protein 1; 0/Insulin-Like Growth Factor Binding Proteins; 0/Pregnancy Proteins; 0/Reagent Strips

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Association of fibrinogen and C-reactive protein with severity of preeclampsia.
Next Document:  A prospective population-based study of 598 cases of PPROM between 24 and 34 weeks' gestation: descr...